Welcome to our newsroom.
Emmes today announced that it provided the data management support for a study, funded by the National Institutes of Health (NIH) and approved by the Food and Drug Administration (FDA), to safely use Acyclovir to treat infants infected with the Herpes Simplex Virus. Acyclovir, known by the brand name Zovirax, now includes recommended usage and dosage for newborns and infants up to three months of age on its label.All Press Releases Download
The EMMES Corporation today announced that it has been awarded an indefinite delivery, indefinite quantity (IDIQ) contract to become part of a clinical studies network established by the Biomedical Advanced Research and Development Authority (BARDA) to perform studies needed to develop medical countermeasures against agents of bioterrorism, pandemic influenza, and other public health threats.Download
When she was young, Anne Lindblad was interested in medicine, even becoming a physician, until she came face-to-face with the inevitable frog to dissect in high school biology class.Download
The EMMES Corporation today announced that Dr. Anne Lindblad, executive vice president, has been promoted to president and chief executive officer. Lindblad replaces Dr. Donald (Don) Stablein, who has been named past president.Download